Developments in auxiliary examination of Creutzfeldt-Jakob disease  

作　　者：Wei Zhao Jiao-Jiao Jiang Jia-Tang Zhang 

机构地区：[1]Department of Neurology,Chinese People’s Liberation Army General Hospital,Beijing100853,China [2]Shijingshan Teaching Hospital of Capital Medical University,Beijing Shijingshan Hospital,Beijing100043,China

出　　处：《Neuroimmunology and Neuroinflammation》2017年第7期136-144,共9页神经免疫与神经炎症（英文版）

摘　　要：Creutzfeldt-Jakob disease (CJD), which is caused by prion scrapie protein, is a rare, chronic, transmissible and fatal disease. Clinical manifestations of CJD include rapidly progressive dementia, cerebellar ataxia, visual disturbance, as well as pyramidal and extrapyramidal tract signs. Four subtypes of CJD have been reported, including sporadic, familial or genetic, iatrogenic and variant. Given the infectiousness and high mortality of the disease, it is imperative that earlier and more accurate diagnostic methods are developed. In the past years, 14-3-3 protein testing and periodic sharp wave complexes in electroencephalogram have been widely used in CJD clinical diagnosis;and the abnormal hyper-intensity in diffusion weighted imaging has also been used. Recently, there has been a focus on the diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography. New findings of potential biomarkers in cerebrospinal fluid and decreases in diffusion tensor imaging measures have emerged as having an association with CJD. Magnetic resonance spectroscopy has also drawn attention as an emerging method for diagnosis. In this review, the progress in auxiliary examinations of CJD is discussed and the potential, future diagnostic methods are introduced.

关 键 词：CREUTZFELDT-JAKOB disease 14-3-3 protein ELECTROENCEPHALOGRAM DIFFUSION weighted IMAGING DIFFUSION tensor IMAGING magnetic resonance spectroscopy 18F-FLUORODEOXYGLUCOSE POSITRON emission tomography/computed tomography 

分 类 号：R73[医药卫生—肿瘤]